In initial studies, SSRIs failed to alter immobility in 5-HT1A mutant mice, suggesting that 5HT1A receptors are critical for the expression of AD-like responses to SSRIs (Mayorga et al., 2001; Santarelli et al., 2003). This evidence concerns the gene HTR1A and Alzheimer disease.